HI CARPET CLEANER LTD
Company number 13101731 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
HI CARPET CLEANER LTD - Analysis Report
Company Number: 13101731
Analysis Date: 2025-07-29 14:43 UTC
Financial Health Assessment for HI CARPET CLEANER LTD (as of 31 December 2024)
1. Financial Health Score: D
Explanation:
HI CARPET CLEANER LTD exhibits significant financial stress with persistent net liabilities and negative shareholder funds. While there is some recent improvement in working capital, the company remains in a precarious position given its negative net assets and long-term liabilities exceeding total assets. This grade reflects symptoms of financial distress indicating the company is not currently in a healthy financial state.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Net Assets (Shareholders Funds) | £-2,680 | Negative net assets indicate the company owes more than it owns; an unhealthy sign akin to an “organ failure” warning. |
| Net Current Assets (Working Capital) | £3,560 | Positive working capital in 2024 suggests improvement in short-term liquidity — a “healthy pulse” compared to previous years. |
| Fixed Assets | £4,600 | Declining fixed assets reflect potential asset disposals or depreciation; may limit operational capacity. |
| Current Liabilities | £5,187 | Reduced from prior years, indicating some short-term debt management improvements. |
| Long-Term Liabilities | £10,120 | Significant long-term debt burden, which weighs heavily on the company’s financial “heart.” |
| Share Capital | £1.00 | Minimal share capital, indicating limited equity buffer against losses. |
| Employee Count | 1 | Very small operation, typical for a micro-entity but also reflects limited human resources for growth or diversification. |
3. Diagnosis: Financial Condition Analysis
HI CARPET CLEANER LTD shows symptoms of financial distress primarily due to:
- Negative Net Assets: The company’s liabilities exceed its assets by £2,680 in 2024, signaling insolvency on a balance sheet basis. This is akin to a patient having a critical deficiency in vital organs.
- Improved Working Capital: After years of negative net current assets (e.g., -£6,952 in 2023), the company reversed this trend to a positive £3,560 in 2024. This is a positive sign, suggesting improved cash flow management or reduction in short-term obligations.
- Heavy Long-Term Debt: Long-term liabilities increased to £10,120 in 2024, which is a significant burden relative to asset base. This is like chronic hypertension putting strain on the cardiovascular system.
- Shrinking Fixed Assets: Fixed assets have declined (from £12,000 in 2021 to £4,600 in 2024), which might reflect asset sales or depreciation, limiting future earning capacity.
- Micro-Entity Status: The company qualifies as a micro-entity, so accounting disclosures are limited, which can obscure full financial clarity.
- Single Director and Shareholder: The company's control is highly concentrated, increasing both agility and risk due to reliance on one individual.
Overall, the company is showing signs of struggle but with some recent improvements in liquidity. Without intervention, the long-term prognosis is guarded.
4. Prognosis
- Short-Term Outlook: The positive shift in working capital is a hopeful sign, suggesting the company might manage immediate obligations better moving forward.
- Long-Term Outlook: Persistent negative net assets and heavy long-term liabilities mean ongoing financial health risks. Without capital injection or debt restructuring, the risk of insolvency or formal insolvency procedures remains elevated.
- Operational Risks: Limited fixed assets and a single employee/director may constrain growth and resilience.
5. Recommendations: Steps to Improve Financial Wellness
Capital Injection or Debt Restructuring:
Seek additional equity investment or negotiate with creditors to restructure long-term debt. This would strengthen the company’s financial “immune system.”Improve Cash Flow Management:
Continue efforts to maintain positive working capital by managing receivables, payables, and inventory efficiently—this is akin to improving circulation.Cost Control and Asset Utilization:
Review operational expenses and ensure fixed assets are optimally used or consider leasing rather than owning to preserve cash.Business Development:
Invest in marketing and client acquisition (leveraging the active website and social media presence) to increase revenue streams.Regular Financial Monitoring:
Implement monthly financial reviews to detect early warning signs (symptoms) and respond proactively.Seek Professional Advice:
Engage accountants or financial advisors experienced in turnaround strategies to support recovery.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.